https://www.commonhealthsolutions.com/blog daily 0.75 2020-11-20 https://www.commonhealthsolutions.com/blog/a-few-quick-thoughts-on-president-trumps-new-executive-order monthly 0.5 2020-09-14 https://www.commonhealthsolutions.com/blog/wait-can-he-do-that monthly 0.5 2020-09-15 https://www.commonhealthsolutions.com/blog/fri-yay-on-a-monday monthly 0.5 2020-09-14 https://www.commonhealthsolutions.com/blog/fri-yay-a-juan-soto-appreciation-post monthly 0.5 2020-09-18 https://www.commonhealthsolutions.com/blog/strongreference-pricing-in-part-d-will-manufacturers-play-ballstrong monthly 0.5 2020-09-16 https://www.commonhealthsolutions.com/blog/international-reference-pricing-what-about-part-d-plan-sponsors monthly 0.5 2020-09-17 https://www.commonhealthsolutions.com/blog/drug-pricing-reform-and-the-biden-administration monthly 0.5 2020-09-17 https://www.commonhealthsolutions.com/blog/wapo-story-on-drug-pricing-misses-opportunity-to-talk-biosimilars monthly 0.5 2020-09-25 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f6a0aab85b77a096d6cdfee/1600785125738/Blog+Table+1.PNG Blog - WaPo Story on Drug Pricing Misses Opportunity to Talk Biosimilars Rituximab is used off-label for the treatment of multiple sclerosis (MS). This table uses a dose of 500 mg or 1,00 mg, based on this Neurology study. The Washington Post article does not specify which dose the patient takes. https://www.commonhealthsolutions.com/blog/election-hail-mary-200-rx-discount-cards-for-seniors monthly 0.5 2020-09-25 https://www.commonhealthsolutions.com/blog/importation-oh-yeah-this-happened-too monthly 0.5 2020-09-25 https://www.commonhealthsolutions.com/blog/fri-yay-dcs-giant-panda-cub monthly 0.5 2020-09-25 https://www.commonhealthsolutions.com/blog/proposal-looks-to-expand-access-to-affordable-insulin-and-epinephrine-impact-unclear monthly 0.5 2020-09-28 https://www.commonhealthsolutions.com/blog/facing-the-practical-challenges-of-importation monthly 0.5 2020-09-28 https://www.commonhealthsolutions.com/blog/fri-yay-happy-birthday-president-carter monthly 0.5 2020-10-02 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f7610a9f1571712a2aa7e25/1601573061883/Jimmy-Carter-Peanut-Of-Plains-Statue-Plains-Georgia-510x680.jpg Blog - Fri-YAY: Happy Birthday, President Carter! - The first biography of the ex-President was released on Tuesday of this week. A new documentary on the former' President’s relationship with the music industry is available via streaming cinema and is on my “to watch” list this weekend. Happy Birthday Mr. President! https://www.commonhealthsolutions.com/blog/fri-yay-baby-yoda-goes-west monthly 0.5 2020-10-09 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f77692491767852beb44f1b/1601661317858/120378313_119249946598587_7720483655881813996_n.jpg Blog - Fri-YAY: Baby Yoda Goes West Safety first! The Child received a COVID-19 test in Colorado. Thankfully, they tested negative! https://www.commonhealthsolutions.com/blog/fri-yay-the-kids-are-alright monthly 0.5 2020-10-16 https://www.commonhealthsolutions.com/blog/democrats-announce-investigation-into-trumps-part-d-copay-cards monthly 0.5 2020-10-15 https://www.commonhealthsolutions.com/blog/me-waiting-for-more-details-on-the-part-d-co-payment-cards monthly 0.5 2020-10-26 https://www.commonhealthsolutions.com/blog/proposal-would-broaden-medicare-beneficiary-access-to-home-infusion-therapy monthly 0.5 2020-10-28 https://www.commonhealthsolutions.com/blog/feds-rely-on-transparency-rule-to-expose-rx-rebates monthly 0.5 2020-10-30 https://www.commonhealthsolutions.com/blog/trying-to-lower-list-prices-for-drugs-trump-administration-removes-rebate-safe-harbor monthly 0.5 2020-11-20 https://www.commonhealthsolutions.com/blog/new-model-would-recalibrate-medicare-payment-for-top-50-part-b-drugs monthly 0.5 2020-11-20 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5fb84418af127900f87c535d/1605911624402/MFN+Chart.PNG Blog - New Model Would Recalibrate Medicare Payment for Top 50 Part B Drugs https://www.commonhealthsolutions.com/blog/category/Medicare+Part+B monthly 0.5 https://www.commonhealthsolutions.com/blog/category/Medicare monthly 0.5 https://www.commonhealthsolutions.com/blog/category/2020+Election monthly 0.5 https://www.commonhealthsolutions.com/blog/category/Medicare+Part+D monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Congress monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Biosimilars monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Importation monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Most+Favored+Nation monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Childish+Bambino monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Fri-YAY monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Prescription+Drug+Pricing monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Epinephrine monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Part+D+drug+pricing monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Part+B+drug+pricing monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Medicare monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/2020+Election monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Center+for+American+Progress monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Panda+Cam monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/340B monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Center+for+Medicare+and+Medicaid+Innovation monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Executive+Orders monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/CMS monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Smithsonian+National+Zoo monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Insulin monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/President+Trump monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Executive+Order monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Medicare+Part+B monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Drug+Pricing monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/International+Reference+Pricing monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Washington+Nationals monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/HRSA monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Copayment+Cards monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Safe+Harbor monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Rebates monthly 0.5 https://www.commonhealthsolutions.com/blog/tag/Medicare+Part+D monthly 0.5 https://www.commonhealthsolutions.com/contact daily 0.75 2020-09-02 https://www.commonhealthsolutions.com/about-us daily 0.75 2020-10-30 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f60ff469bc1cc2f63f7dc6f/1600192401313/IMG_1133.jpg About Us - About Melissa Andel Melissa Andel, MPP, is the principal of CommonHealth Solutions. Melissa has extensive experience in the pharmaceutical manufacturer and health care payer industries. She started CommonHealth Solutions to provide smart, collaborative, and flexible consulting services to life science companies. Her goal is to help clients understand public policy and market access challenges so they can focus on serving their patients. Before starting CommonHealth Solutions, Melissa served as Vice President of Health Policy for Applied Policy, a health policy consulting firm located in Alexandria, Virginia. As Vice President, Melissa directed and managed the firm’s portfolio of pharmaceutical manufacturer clients, helping solve market access problems for existing products and working with brand teams to identify opportunities and potential challenges for upcoming products. Melissa is well versed in Medicare Part D, Medicaid, and commercial pharmacy benefits. Prior to joining Applied Policy, she worked at the Academy of Managed Care Pharmacy (AMCP), in Alexandria, Virginia. Her last role at AMCP was as Assistant Director of Legislative Affairs, in which she worked directly with AMCP leadership to develop and articulate Academy policy on a wide range of issues impacting prescription drugs and the practice of pharmacy. In 2020, Melissa was appointed as an adjunct lecturer at the University of Florida’s College of Pharmacy, where she is responsible for developing and teaching a graduate-level course on prescription drug policy in the Department of Pharmaceutical Outcomes and Policy. Melissa has a Bachelor of Arts degree in Journalism and Public Relations from the University of Georgia and a degree of Master of Public Policy with a concentration in Global Health and Medical Policy from George Mason University. https://www.commonhealthsolutions.com/services daily 0.75 2020-10-30 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f3d74f56ba7d21ccf990ffa/1597863164156/Icons-03.png Services Plan for the launch of new products and break down coding timelines and coverage and payment environments. https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f3d749e75cc6f6b545aef1b/1597863079151/Icons-02.png Services Review proposed regulatory actions from the Centers for Medicare and Medicaid Services, as well as Congressional and Presidential proposals, and analyze potential impact on manufacturers, providers, and patients. https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f3d74c25256010f80f36852/1597863113033/Icons-01.png Services Address market access challenges for new and existing products with collaborative and innovative strategies. https://www.commonhealthsolutions.com/home daily 1.0 2020-09-15 https://static1.squarespace.com/static/5f2c53b66cf3bb4739e24c95/t/5f3c042c1ad7dc3ab597b96e/1597768787097/Untitled-3-04.png Home